Peter Attia· MD
again I think it's a it's a it's a it's a remarkably poultry sum that is spent on this when you consider the utility that can come of this especially with some of the other um I don't want to use the word ancillary because that's almost disparaging in the sense but these other sort of ACC creative tools that are being bundled onto it such as the neurocognitive assessment uh and the and the Aging biomarkers